Papers

4

Total Citations

40

H-Index

3

About

Zhitao Gu is a leading thoracic surgeon whose work centers on optimizing surgical outcomes for thymic malignancies and advancing the quality of care in thoracic surgery. His most impactful contribution is a landmark international study comparing surgical approaches for Masaoka-Koga Stage I and II thymic tumours, which drew on data from the International Thymic Malignancy Interest Group across Europe, North America, and Asia. This work, with 27 citations, provides critical evidence on how variations in surgical technique and extent of resection affect patient prognosis, helping to standardize best practices worldwide. Beyond this, Dr. Gu has been instrumental in institutional transparency and quality improvement, authoring a series of annual reports for the Thoracic Surgery Service at Shanghai Chest Hospital. These reports, spanning 2018 to 2021, systematically document surgical volumes, outcomes, and key achievements, serving as a model for data-driven clinical governance. Through his rigorous research and commitment to reporting, Dr. Gu has shaped both the evidence base for thymic tumour surgery and the culture of accountability in modern thoracic surgery.

Research Focus

Key Achievements

3
H-Index
4
Papers
40
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of surgical approach and extent of resection for Masaoka-Koga Stage I and II thymic tumours in Europe, North America and Asia: an International Thymic Malignancy Interest Group retrospective database analysis†
27 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Shanghai Chest Hospital, Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago